ALTENGIO Trademark

Trademark Overview

On Saturday, August 27, 2016, a trademark application was filed for ALTENGIO with the United States Patent and Trademark Office. The USPTO has given the ALTENGIO trademark a serial number of 79195697. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 29, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The ALTENGIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
altengio

General Information

Serial Number79195697
Word MarkALTENGIO
Filing DateSaturday, August 27, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 29, 2023
Registration Number5220477
Registration DateTuesday, June 13, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Tuesday, November 22, 2016APPLICATION FILING RECEIPT MAILED
Thursday, November 10, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, November 15, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, November 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 2, 2016ASSIGNED TO EXAMINER
Monday, December 5, 2016NON-FINAL ACTION WRITTEN
Tuesday, December 6, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 6, 2016REFUSAL PROCESSED BY MPU
Tuesday, December 6, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 30, 2016REFUSAL PROCESSED BY IB
Monday, January 16, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 2, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 2, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 8, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 8, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, September 19, 2017FINAL DISPOSITION PROCESSED
Tuesday, September 19, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, October 6, 2017NOTIFICATION PROCESSED BY IB
Friday, May 4, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Monday, June 13, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 29, 2023CANCELLED SECTION 71
Friday, August 30, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, September 10, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, September 10, 2024INVALIDATION PROCESSED
Monday, September 30, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Friday, May 18, 2018CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

Related Keywords

altengio system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary